Willis Towers Watson is a global insurance broker and human capital advisory firm, placing commercial risk and reinsurance and running benefits administration and compensation consulting for employers. Its scale in commercial and specialty risk brokerage, combined with recurring fee-based revenue from benefits and consulting mandates, gives it a durable base that is hard for smaller brokers to replicate across multiple countries. Revenue grew 9.1% and return on equity sits at 19.8%, with a 17.6% operating margin, which points to pricing power holding up through a soft-ish insurance pricing cycle. The stock trades at 13.0 times forward earnings against 18.5 times trailing, so the market is pricing in a meaningful earnings step-up that the next few reporting periods will need to confirm. The score of 59 out of 100 and absence from major indices suggest the name is under-followed, which is worth testing against whether that discount reflects organic growth slowing or simply a lack of sponsorship.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 19 Oct 2026, 19:04 CEST | Fair value | $210 | $188 | $315 |
| 19 Oct 2026, 19:04 CEST | Rating | Overvalued | first publication | $315 |
| 11 Oct 2026, 00:00 CEST | Fair value | $188 | $208 | $296 |
| 1 Oct 2026, 00:00 CEST | Fair value | $208 | $213 | $289 |
| 26 Sept 2026, 00:00 CEST | Fair value | $213 | $215 | $294 |
| 24 Sept 2026, 00:00 CEST | ACCE price target | $320 | first publication | $302 |
| 24 Sept 2026, 00:00 CEST | Fair value | $215 | $219 | $302 |
| 14 Sept 2026, 00:00 CEST | Fair value | $219 | $222 | $316 |
| 10 Sept 2026, 00:00 CEST | Fair value | $222 | $227 | $325 |
| 31 Aug 2026, 00:00 CEST | Fair value | $227 | $213 | $340 |
Answered from Willis Towers Watson Public Limited Company Ordinary Shares fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| WTW Willis Towers Watson Public Limited Company Ordinary Shares | $325.01 | $210 | 55% above | 20.6x | 19.8% | 75 | 62 |
| BRO Brown & Brown Inc. Common Stock | $72.97 | $60 | 21% above | 23.5x | 10.0% | 74 | 71 |
| AON Aon plc Class A Ordinary Shares (Ireland) | $303.52 | $202 | 51% above | 16.2x | 44.7% | 78 | 52 |
| AJG Arthur J. Gallagher & Co. Common Stock | $268.04 | $116 | 131% above | 44.9x | 6.7% | 67 | 62 |
| ERIE Erie Indemnity Company Class A Common Stock | $253.52 | $143 | 77% above | 23.0x | 24.8% | 70 | 48 |
| RYAN Ryan Specialty Holdings Inc. Class A Common Stock | $43.68 | $23 | 87% above | 61.5x | 22.1% | 64 | 52 |
| MRSH Marsh Common Stock | $197.48 | $121 | 63% above | 22.8x | 27.2% | 80 | 70 |
Where WTW ranks against its sector peers on each metric.